Filing Flows › Neuronetics (STIM) › Q3 2025
Neuronetics (STIM) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 4, 2025
Neuronetics (STIM) reported revenue of $37.3M for the third quarter 2025 (Q3 2025), +101% from a year earlier and -2% from the quarter before. Operating margin was -19.6%, net loss $9.4M (25.2% of revenue).
Neuronetics, Q3 2025: revenue $37.3M (+101% year over year), operating margin -19.6%, net loss $9.4M, operating cash flow −$785K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $37.3M | -2% | +101% |
| Operating profit | −$7.3M | — | — |
| Net earnings | −$9.4M | — | — |
| Operating cash flow | −$785K | — | — |
What changed
Revenue was $37.3M in Q3 2025, up 101% year over year and down 2% from the previous quarter.
Gross margin was 45.9%. Operating costs exceeded revenue by $7.3M, an operating margin of -19.6%. The quarter ended with a net loss of $9.4M, narrower than the previous quarter's $9.8M loss. Minority interests bore $356K of it: to shareholders the quarter was a loss of $9.0M.
Operating cash flow was −$785K. Non-cash charges added back $886K of depreciation and amortization and $1.4M of share-based compensation. Working capital and other items added $6.3M. Capital expenditures of $114K exceeded it, leaving free cash flow of −$899K.
Questions
What was Neuronetics' revenue in the third quarter 2025?
Neuronetics (STIM) reported revenue of $37.3M for the third quarter 2025 (Q3 2025), +101% from a year earlier and -2% from the quarter before.
Was Neuronetics profitable in the third quarter 2025?
Operating loss was $7.3M (-19.6% of revenue) and net loss $9.4M.
Source: Neuronetics 10-Q on SEC EDGAR.